Comprehensive Data Analytics Suite: Access AGMRI Insights and AGMRI Analyze for full-season analytics during the 2024 crop season.
Yield Potential Focus: AGMRI Analyze tracks nine common yield-limiting factors.
Strategic Decision Support: Utilize a comprehensive report for informed decision-making in preparation for the next year’s crop season.
Intelinair, the makers of AGMRI and a leading ag data analytics company, announced the latest addition to its suite of data analytics for the 2024 crop season – AGMRI Analyze. AGMRI Insights, the in-season analytics suite, will continue to be available to inform real-time data-driven decision-making.
AGMRI Analyze monitors nine common yield-limited factors, enabling farmers to pinpoint and understand potential issues that have impacted their yield during the season. This data-driven approach helps farmers make informed decisions for the upcoming crop season, ultimately contributing to improved efficiency and yield potential.
“With the addition of Analyze, we have created a more complete data analytics package that farmers can rely on for both in-season monitoring and postseason analytics,” said Tim Hassinger, Intelinair president and CEO. “Our team identified nine common rate-limiting factors based on feedback from AGMRI users, and we’ve integrated them into this new capability for the 2024 season. By consolidating in-season and postseason analytics into a unified platform, we’re taking real-time and postseason data-driven decision-making to the next level.”
Highlights of AGMRI Insights and AGMRI Analyze:
Covers in-season agronomic insights:
Emergence
Weeds
Crop Health – Disease, Nutrient Deficiency, and Underperforming Areas
Variable Dry Down
Covers postseason data analytics:
Emergence
Nutrient Availability
Crop Stress
Disease
Hybrid and Variety
Weather
Soil
Machine
Crop Input Product Performance
Use Case: Using AGMRI Analyze to Measure Emergence Impact on Yield
Measured emergence helps farmers determine the emergence percentage and how well hybrids or varieties performed. With this information, a farmer can explore which hybrids or varieties had a combination of good emergence and yield and answer key questions for planning for the next crop season.
Potential Impact on Yield
AGMRI Analyze measures every plant throughout the field for emergence and can correlate actual emergence back to many factors to help understand which ones impacted emergence and the final field yield.
Key Data Provided:
Emergence % = Emerged Plants/Planted Seeds
Yield/1000 Plants = Final Yield/1,000 Emerged Plants
Questions for Next Year’s Crop Season Planning
Do I need to adjust my planting rates
How does my emergence compare to others?
Am I getting a good yield for emerged plants?
Any tillage or residue management changes needed?
Did the planting date impact emergence?
“If a hybrid or variety had poor emergence but still produced a good yield per 1,000 plants, a farmer can explore varied factors such as soil conditions, soil types, weather, planter speed, and other factors that might have limited the emergence potential of those specific hybrids and varieties,” said Conner Schmidt, Intelinair national sales leader. “If good emergence relative to planted rate exists and a poor yield occurs, then a grower may want to reconsider the placement of those hybrids and varieties or possibly eliminate them altogether from their product selection.”
Schmidt added, “Other factors to investigate are nutrient deficiencies, disease, or crop stress on how they impacted the final yield.”
For more information about Intelinair, AGMRI Insights and AGMRI Analyze, or how to sign up for the 2024 season, visit https://www.intelinair.com/agmri.
About Intelinair Intelinair provides whole field insights all season long to farmers and ag retailers through its easy-to-use interactive platform, AGMRI. Through AGMRI Insights and AGMRI Analyze, Intelinair’s proven data analytics capabilities tracks every acre, every factor – emergence & population impacts, nutrient utilization, hybrid and variety performance, and even weather impact – for data-driven in season and postseason decision making and identifies sustainability opportunities. Learn more at Intelinair.com or visit our social media channels.
Breakthrough software and services reduce grower resource usage and costs while increasing volume and quality
Boyd Street Ventures announced that it has become the lead investor in VinSense, LLC, whose innovative decision support software system and services enable agricultural crop producers to optimize their use of water, fertilizers and other resources while increasing their crop yields, quality and prices.
VinSense’s mission is to address the serious challenges faced by crop growers due to climate change and rising costs of water, labor, fertilizers and other resources. The company has developed a proprietary and highly effective approach to precision soil management to meet growers’ needs.
“VinSense technology transforms soil data, microdata, historical data and precision soil maps into intuitive, easy-to-use visual information to increase the effectiveness of the decisions growers make throughout the season,” said Dr. David Ebert, developer of the technology and VinSense Co-Founder and Chief Technology Officer. “This allows growers to optimize water and resource management to achieve the best possible combination of quantity, quality, uniformity and cost from their crops.”
VinSense’s customers include numerous California and Washington wineries, including Robert Biale Vineyards, Cakebread Cellars, Francis Ford Coppola Winery, Ridge Vineyards, and Silver Oak. The company will be moving its headquarters from Northern California to Norman, Oklahoma, where Dr. Ebert is Gallogly Chair Professor of Electrical and Computer Engineering and the Director of the Data Institute for Societal Challenges.
“We’re very excited to become the lead investor in a Smart Agriculture innovator that brilliantly and economically addresses many of the most serious threats climate change and rising costs are creating for growers of wine grapes and other important crops,” said James Spann, Boyd Street Ventures Founder and General Partner. “We’re also very proud that VinSense is relocating to our home city of Norman, and we look forward to helping the company grow its revenues and create new job opportunities for Oklahomans.”
ABOUT BOYD STREET VENTURES
Boyd Street Ventures is a groundbreaking, early-stage venture capital firm connecting institutional and other investors to high-growth investment opportunities founded and developed by entrepreneurs from Oklahoma and elsewhere. BSV places Pre-Seed, Seed, Series A and follow-on investments in the Life Sciences, FinTech, Energy Tech, Aerospace & Defense, and Climate Tech sectors. The firm focuses on under-the-radar startups that are less likely to have their prices overbid and overpriced than startups targeted by larger VC firms on the East and West Coasts. This focus, coupled with its unusually active involvement in providing de-risking strategic and operational counsel to its portfolio companies through its Boyd Street Venture Studio, enables BSV to target above-average returns for its investors. For more information, please visit https://www.boydstreetventures.com/
Name: Julia Hamblen University: Purdue University Major/Minor: Agricultural Education with a Wood Products Manufacturing Technology Minor Semesters as a Field Atlas Ambassador: 5 Semesters
What do you enjoy most about the role?
I enjoy having the creative freedom to discover new ways to educate others on AgBioScience. I love everything about education, and this role allows me to conduct this in new and innovative ways all the time.
What has surprised you most about the agbiosciences?
It never ceases to amaze me how AgBioScience is an industry that truly affects every single person on this planet no matter where we are. I think it is so cool to be able to advocate and educate on an industry that touches all of us and to watch those “ah-ha” moments when I am talking to someone else about AgBioScience when they realize how cool the industry is as well.
Which agbioscience company interests you most, and why?
I may be a little biased, but I will have to say Indiana Soybean Alliance. I had the chance to intern with them in the summer of 2022, and it was one of the best experiences I have ever had. I had the chance to work in the Glass Barn and see all of the behind-the-scenes of renovating it that summer, and it was such a fun process to see progress and watch all of the kids learn about soybeans. Seeing their efforts surrounding education was exciting to be a part of.
How can students get in touch with you?
I can be reached at my AgriNovus email, [email protected].
Today’s guest is an entrepreneur who got her skills in organizing business systems where any young talent might consider learning efficiency: the Chick-fil-a drive-thru. Sarah Hinkley, CEO of Barn Owl Precision Ag, actually helped to build the fast-food chain’s drive-thru system as we know it today (alongside her brother). Watching a major company leverage technology to solve problems really inspired Sarah and from that, a company was born.
Sarah gets into Barn Owl’s inception, creating new innovation to supplement a massive labor problem and listening to what growers need today, tomorrow and what would be nice in the future. She dives into how a Barn Owl robot functions and what factors are driving the need for more agility on-farm. As a serial minded entrepreneur, Sarah also provides insight into launching an idea into a business, creating solutions to problems and making a difference through your work (even when it hurts).
Ryan Priest is no stranger to hard work and servant leadership, assets that have been integral to his role as COO at Premier Ag Cooperative today. And as someone that has done many jobs – from welding to executive leadership – he identified a problem that needed a new, fresh idea to solve: developing an emerging workforce that’s equipped with the tools to understand farmers, the broader agbioscience economy and the technical knowledge required to be successful in the industry.
Ag equipment today has more in common with an airplane than a pickup truck and there is an under-appreciated level of knowledge required to operate this machinery. Ryan talks about Premier’s cutting-edge work-based training program with Ivy Tech designed for workers to better understand and function in high-tech agriculture. He notes the ripple effect of talent starting in the program and learning more about the industry, and the earning potential for someone in the program.
Mitch Frazier recently joined Ryan’s podcast, The High Ground, which can be heard here: https://www.premierag.com/2024/01/ep-119-agrinovus-consumer-electronics-show-ces-favorite-purchase/
Get to know your campus ambassador in our intro video here:
BiomEdit, an emerging animal health biotechnology company, announced today that it has received a $4.5M grant from the Bill & Melinda Gates Foundation to accelerate research and development of a portfolio of novel microbiome-based solutions to reduce methane emissions that also enhance feed efficiency for beef and dairy cattle. This innovation has the potential to significantly impact agricultural greenhouse gas (GHG) emissions and enhance the livelihood of small-scale producers and pastoralists in sub-Saharan Africa and South Asia, where cattle are a vital source of income.
FISHERS, Ind., Nov. 1, 2023 –– BiomEdit, an emerging animal health biotechnology company, announced today that it has received a $4.5M grant from the Bill & Melinda Gates Foundation to accelerate research and development of a portfolio of novel microbiome-based solutions to reduce methane emissions that also enhance feed efficiency for beef and dairy cattle. This innovation has the potential to significantly impact agricultural greenhouse gas (GHG) emissions and enhance the livelihood of small-scale producers and pastoralists in sub-Saharan Africa and South Asia, where cattle are a vital source of income.
As the number one agricultural source of greenhouse gases worldwide, ruminants like cattle produce methane as part of their normal digestive process. Methane is a major contributor to climate change and each year a single cow alone will belch about 220 pounds of methane. According to the International Livestock Research Institute (ILRI), livestock contribute up to 80 percent of developing countries’ agricultural GDP and they serve as an important source of nutrition and livelihood for small-scale producers and pastoral communities. Finding a way to reduce methane emissions in native cattle in their local habitat while increasing productivity is key to environmental and economic sustainability, particularly for Africa and South Asia.
“To meaningfully impact climate change, there must be a simultaneous benefit of reducing methane emission in cattle plus redirecting spare energy, which would otherwise go to creating methane, to increasing feed efficiency for nutritious meat and milk,” said Aaron Schacht, CEO of BiomEdit.
BiomEdit’s solutions will target the rumen microbiome, which is the community of microorganisms that live in a cow’s digestive tract. The rumen microbiome plays a key role in digestion, with specific microorganisms responsible for methane production. The company will take a multi-pronged approach to leverage natural and synthetic probiotics and bioactives that robustly reduce methane emissions and increase cattle performance by inhibiting energy losses through methanogenesis and enhancing production of volatile fatty acids (VFA, the main source of energy from the rumen). Pathways to administer the innovations could take the form of feed additives, feed supplements, veterinary biologics, or pharmaceuticals.
“To make a meaningful impact on climate change, there must be a simultaneous benefit of reducing methane emission in cattle plus redirecting the spare energy, which would otherwise go to creating methane, to increasing feed efficiency so everyone can benefit from nutritious meat and milk – no matter where they are in the world. The answer is found through the microbiome and synthetic biology,” said Aaron Schacht, CEO of BiomEdit. “We are grateful for the Bill & Melinda Gates Foundation’s belief in our Methane Reduction R&D program, and excited to partner with them to enable both large- and small-scale producers to benefit from the innovations.”
A range of current strategies for methane reduction are in development or on the market, however, direct inhibition of methanogens has shown the largest effect on mitigating enteric methane emissions. An issue with many products currently available is farmers must fund an additional input to gain methane emission reduction and feed efficiency, so they do not often see a sufficient return on investment. Developing methane mitigation products that can improve production efficiency and pay for themselves will make this approach financially feasible for farmers, encouraging them to participate.
BiomEdit’s Development Platform and People
BiomEdit’s research is based on their unique platform combining well-curated microbial reference libraries, microbiome analytics, synthetic biology, and artificial intelligence (AI) to develop novel biologic products targeting significant challenges facing animals, humans, and our shared habitat.
As pioneers in the application of AI and machine learning in animal health, patterns and relationships are identified in the data to generate novel insights into how an animal’s microbiome shifts as it transitions from health to disease and back again – leading to a deeper level of knowledge about how the microbiome functions as an ecosystem.
The BiomEdit team is a diverse group of innovators with an entrepreneurial spirit: scientists with deep expertise in microbiome science and product development. The Methane Reduction R&D program team alone holds over 50 patent applications and more than 200 peer-reviewed scientific publications. The company also plans to collaborate with leading experts in rumen microbiome analysis at key academic research institutions on this project.
Keeping livestock producers’ livelihoods in mind, BiomEdit announced in October a first-of-its-kind collaboration with Athian, the world’s first cloud-based carbon marketplace for the livestock industry, to develop sustainability protocols and products in parallel. The company helps livestock producers capture and claim carbon credits earned through sustainability efforts by aggregating, validating, and certifying greenhouse gas (GHG) reductions, and monetizing those reductions for the producer through the sale of carbon insetting credits.
About BiomEdit
BiomEdit is an emerging animal health biotechnology company that leverages a unique platform combining the leading science of the microbiome with synthetic biology to innovate novel animal health products to address challenges in livestock production and pet health. Founded through a strategic partnership in 2022 between Elanco Animal Health (NYSE: ELAN) and Ginkgo Bioworks (NYSE: DNA), the company was born from a carve-out of technology and assets from Elanco combined with access to Ginkgo’s leading cell programming platform technology. BiomEdit is a private venture funded by Anterra Capital, Viking Global Investors, Ferment, and Nutreco Ventures. In 2022, BiomEdit was recognized by S&P Global Animal Health as Best Start-up in Animal Health in its annual animal health industry awards. www.biomedit.com
Forbes – the global business media powerhouse – named Indiana the best place to start a business in 2023. It’s one of many recent wins on the board for Indiana – a trophy case that includes everything from securing commitments for $33B in capital investment in the last six quarters to securing the rights to host the next Global Entrepreneurship Congress. It’s momentum that today’s guest seeks to continue. Indiana Secretary of Commerce David Rosenberg joins us to look into the future, poising Indiana for success and retaining young talent in state for generations to come.
David talks about getting the economy you want versus the one that comes to you, the Indiana Economic Development Corporation (IEDC) becoming a strategic organization and agbioscience’s role in building our state’s future. He also gets into Indiana’s evolving talent pipeline and creating the necessary tools for companies to fill jobs. David also talks about growing the state’s entrepreneurial ecosystem, venture’s growth and opportunities in Indiana and shaking the humble Hoosier mindset.
With all this momentum and a little bit of time left under Governor Holcomb’s administration, what’s next for IEDC? David looks ahead at what needs to be done, the strength of their team to make it happen and his excitement for Indiana’s future.
The Indiana State Department of Agriculture (ISDA) announced today that Katie Nelson has been selected as Deputy Director of the Indiana State Department of Agriculture.
“We are so excited to promote a longstanding public servant, like Katie, to second in command for the Indiana State Department of Agriculture,” said Lt. Gov. Suzanne Crouch, Secretary of Agriculture and Rural Development. “I have worked alongside Katie for over six years now and she has been a strong advocate for farmers and agriculture in Indiana. I am sure that she will continue to push this industry forward in the coming years. Congratulations, Katie.”
As deputy director of the department, Nelson will support the director in achieving ISDA’s mission and strategies. Among many responsibilities, she will oversee the day-to-day operations of the department, represent ISDA at events, engage with producer organizations and identify opportunities to grow the state’s agriculture sector.
Nelson has served and will continue to serve as a liaison between agricultural businesses, state agencies and local units of government.
“We are excited to see Katie flourish in this role within our department,” said Don Lamb, director of the Indiana State Department of Agriculture. “Katie has a passion for agriculture, public service and supporting staff. I am hopeful this role will continue to support her as a public servant and bring our staff and department great success.”
Nelson has been with the department since 2017. She was previously Director of Legislative Affairs within the department, a role she has held since 2020. Prior to that she was the program manager of policy and regulatory affairs at ISDA.
Nelson’s past work at ISDA has included evaluating the legislative and regulatory landscape at all levels of government while positioning the department to support Indiana’s agricultural industry. She also served as executive director of the Indiana Land Resources Council, which was created to assist state and local decision-makers with land use tools and policies.
“Working for ISDA over the last several years has provided me with numerous opportunities for personal and professional growth, and allowed me to support my favorite industry, agriculture,” said Nelson. “I am looking forward to this new challenge of supporting our outstanding staff and continuing to pursue the ISDA mission of bettering Indiana agriculture within policy work, growing economically and enhancing our stewardship of natural resources.”
Nelson graduated in December of 2016 from the University of Missouri with a bachelor’s degree in political science. In 2019, Nelson graduated from the Agribusiness Council of Indiana’s Emerging Professionals Leadership Program. Nelson also is a 2021 graduate of the Richard G. Lugar Excellence in Public Service Series. In the summer of 2024, she will become a graduate of the AgriInstitue’s Agriculture Leadership Program, Class 20.
Nelson resides in Franklin with her husband, two children and beloved dog.
Targeted single-dose monoclonal antibody is the first and only treatment for devastating dog disease
GREENFIELD, Ind. (May 2, 2023) – Elanco Animal Health Incorporated (NYSE: ELAN) today announced the U.S. Department of Agriculture (USDA) has provided a conditional license for the first Canine Parvovirus Monoclonal Antibody. This is the first and only approved therapeutic solution proven to treat canine parvovirus — one of the most contagious and deadly viruses a dog can contract with a 91% mortality rate if not treated with supportive care1. The treatment is the first monoclonal antibody for Elanco, an important innovation platform for the company.
With an estimated 330,000 cases of canine parvovirus available for treatment in the U.S. annually2, clinical trials demonstrate that the Canine Parvovirus Monoclonal Antibody single, intravenous dose delivers targeted efficacy in treating this deadly disease. The treatment can be administered to dogs eight weeks of age or older with canine parvovirus. The Canine Parvovirus Monoclonal Antibody treatment may provide a less intensive and more effective solution than supportive care alone by targeting the virus with single dose efficacy and a strong safety profile in healthy dogs.
“Elanco is proud to bring to market this first-in-class treatment that will help save puppies lives, while alleviating the emotional and financial burden of both pet owners and veterinary care teams,” saidJeff Simmons, president and CEO, Elanco. “We’re excited to bring our first monoclonal antibody treatment to market, reinforcing Elanco’s commitment to pioneer new tools in spaces where there aren’t existing options. We’re committed to helping the world’s pets live longer, healthier lives because we believe making life better for our pets makes life better.”
The Canine Parvovirus Monoclonal Antibody is expected to begin shipping in the coming weeks, pending individual state approvals. Elanco will also continue to provide canine parvovirus education and resources to veterinarians, shelter owners and pet parents.
“Today’s announcement is a game changer for pet owners and veterinarians,” said Dr. Kristin Zersen, DVM, DACVECC, assistant professor of small animal emergency and critical care at Colorado State University Veterinary Teaching Hospital. “Parvovirus is an unpredictable disease that causes significant strain on pet owners and is labor intensive and stressful for shelters and veterinary clinic staff. It’s lifechanging and industry-defining to be able to offer a proven solution to canine parvovirus that limits the need for hospitalization, reducing the impact this disease has on hundreds of thousands of dogs each year.”
The conditional license approval—granted by the USDA to effectively and safely meet an emergency situation, limited market or special circumstance—of the first-ever targeted monoclonal antibody treatment for canine parvovirus bridges Elanco’s expertise in both therapeutics and vaccines. In the treatment efficacy study, the Canine Parvovirus Monoclonal Antibody was proven effective in decreasing mortality associated with parvovirus infection.3 Treated dogs also had significantly faster times to resolution of the most-adverse effects of parvovirus including vomiting4, meaning that they feel better faster and get home sooner.
Prior to Elanco’s Canine Parvovirus Monoclonal Antibody, the only treatment for the highly contagious canine parvovirus was supportive therapy, which can consist of 24/7 care, multi-day hospitalization and emotional stress for the staff and pet owner with no guaranteed outcome and potentially high pet owner costs. In conjunction with its portfolio of innovative solutions, this announcement establishes Elanco’s presence in the monoclonal antibody space and reinforces its commitment to helping pets live longer, healthier lives through its portfolio of innovative solutions.
